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ABSTRACT
THREE-DIMENSIONAL SCAFFOLDS FOR MAMMARY EPITHELIAL CELL
GROWTH
By
Megan Barry
Mammary epithelial cells are highly efficient secreting cells. This natural 
phenomenon has triggered research efforts to focus on using these cells to assist in the 
production of viable liquids. The application of this technology is nearly endless. If 
developed successfully, manunary epithelial cells could be used by industries from 
farming to phannacology. 
The feasibility of culturing epithelial mammary cells which secrete within a three­
dimensional scaffold was investigated and is documented within this paper. A 
biocompatible film with suitable mechanical characteristics and processing properties for 
use in a bioreactor was developed through multiple iterations. The film that was 
developed also withstands extended periods of time in an aqueous solution at 37 degrees 
Celsius (the incubation temperature for epithelial cell lines) and can be optimized for cell 
survival (adjustable penneability). A prototype of a self-contained system that facilitates 
the growth of epithelial manunary cells and promotes their secretion of lipid proteins was 
also developed through this exploratory research. 
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Chapter 1. Purpose 
Gene "pharming" is an emerging scientific field with the objective of producing 
genetically altered animals which produce pharmaceuticals. "Pharming" is a portmanteau 
of "farming" and "pharmaceutical" and refers to a practice which represents a projected US 
market value of $3 billion dollars annually. Using genetic engineering to inject genes, 
which code for useful pharmaceuticals, into host animals is a novel idea in theory, but a 
difficult practice to perfect. Mammary tissue is one of the most prolific of all secretory 
tissue, and has been argued to be the ideal site for producing complex bioactive proteins. 
However, creating transgenic cattle requires 1600 egg injections per animal, yielding a 
50% success rate. The inefficiencies associated with "pharming" in mammals including 
low rates of gene integration, poor embryo survival, and unpredictable transgene behavior, 
make the practice very expensive [41]. 
The goal of this project focuses on isolated mammary cells, thereby eliminating 
complications of genetic engineering due to other gene or system interactions. These cells 
are easily cultivated in vitro; however they lose their secretory functions when grown under 
standard cultivating conditions. Therefore the scope of this project is to develop a three-
dimensional scaffold which simulates the physical morphology and chemical gradient of 
the natural environment for mammary cells, with the anticipation that this simulated 
environment will stimulate secretory function. This paper focuses on the development of 
the material systems and bioreactor design for growing mammary epithelial cells in 
synthetic, polarizing alveolar structures that support increased secretion. 
Chapter 2. Background 
Section 2.01 Function ofmammary cells 
Mammary cells are a specific type of epithelial cell, primarily responsible for the 
production of milk proteins. Secretory mammary tissue is organized into lobes, with 
each lobe made up of many lobules. Lobules contain the milk synthesizing units know as 
aveoli. The lumen of each aveoli is lined with a single layer of secretory epithelial cells, 
which in tum is surrounded by contractile myoepithelial cells. The rough endoplasmic 
reticulum, within the secretory cells, synthesizes the milk protiens, which are then 
processed in the Golgi apparatus. Within the Golgi apparatus, casein micelles and lactose 
are produced. These products are stored in secretory vesicles until they are secreted. 
The lumen is connected to a duct system and upon milking stimuli and release of 
oxytocin (a hormone released form the pituitary which begins the milk-let-down process), 
the myoepithelial cells compress the aveoli, putting pressure on the lumen and releasing 
the milk products into the duct system. 
The epithelial cells lining the aveoli are polar in nature, which means that the 
basal side of the cells has distinctly different functions compared with the apical (lumen) 
side. The contents of the cells are polarized such that the nucleus is located on the basal 
half of the cell and the Golgi apparatus along with the secretory vesicles and fat droplets 
are usually located on the apical half. This polarization is key to the secretion milk by 
mammary epithelial cells. 
In order for mammary cells to function similarly in vitro, it is important that the 
same polarization and establishment of the basal and lumen sides (see Figure 1) as well 
as simulation of geometry are achieved. By providing a polarized setting with a nutrient 
supply (basal) side and a secretory (lumen) side, and providing the necessary nutrients for 
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milk production, it is hypothesized that the mammary epithelial cells will be able to 
secrete products in vitro comparable to how they secrete in vivo [14]. 
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Figure 1 Schematic of a mammary alveolus 
(http://www.foodsci.uoguelph.ca/deicon/mammary.gif) 
(a) Tissue Engineering 
Tissue engineering can be thought of as the combining of clinical medicine, 
engineering and science. It involves the 'application of the principles and methods of 
engineering and life sciences towards the fundamental understanding of structure-
function relationships in normal pathological mammalian tissues and the development of 
biological substitutes that restore, maintain or improve tissue function' [29]. The in vitro 
seeding and adhering of cells to a synthetic or organic scaffold is the basis of tissue 
engineering. Therefore, choosing the correct scaffold material is very important in tissue 
engineering [28]. 
Scaffold materials can be made of synthetic or organic materials. Examples of 
synthetic materials include polyglycolic acid (pGA), polylactic acid (PLLA) or 
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polycaprolactone (PCL). These three polymers are the most common synthetic materials 
used for tissues engineering scaffolds. The most popular natural polymer used for tissue 
engineering is collagen [28]. 
(b) Collagen 
Collagens are the primary structural protein in most connective tissues, including 
skin, bone and tendons, where they provide structural support to the tissues [6]. Collagen 
is composed of three polypeptide a-chains, each consisting of over 1000 amino acids 
[13]. Each of the three polypeptide chains are coiled into a left-handed helix and then the 
three are joined together into a right-handed superhelix which is stabilized by interchain 
hydrogen bonds and covalent crosslinks [6]. See Figure 2. 
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Figure 2 Chemical structure of collagen type I. (a) Primary amino acid sequence, 
(b) secondary left handed helix and tertiary right handed triple-helix structure and 
(c) staggered quaternary structure. [13] 
Currently, 13 different types of collagen have been identified, which differ in 
length of helix and nature and size of the non-helical portions [13]. Type I collagen is 
most prominent in higher order animals, and can be isolated from skin, tendon, bone, 
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cornea, dentin, fibrocartilage, large vessels, intestine, and uterus. This type of collagen is 
characterized by two identical polypeptide chains, referred to as aI, and one a2 chain 
with a different amino acid composition. The amino acid compositions for the two 
chains of Type I collagen are listed in Figure 3. Collagen is an attractive material for 
tissue engineering because it is a natural material with low immunogenicity and because 
its structural complexity provides properties not present in synthetic materials. These 
properties can be modified to meet the needs of the material application. For example, 
thermal, chemical or physical denaturation of coHagen breaks down the triple helix into 
single coils, resulting in gelatin [6]. 
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Figure 3 Amino acid composition of type I collagen from calf-skin (the values in 
parentheses are residues contributed by non-helical telopeptide regions) (23) 
(c) Gelatin 
Gelatin is the product of denaturation and structural degradation of collagen. 
Because of this, gelatin has many of the same properties of collagen, but is less 
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expenSIve. To extract gelatin from collagen, the collagen is treated with either alkali or 
acid, which each result in different types of gelatin (see Figure 4). Type A gelatin results 
from acid treatment, which is most commonly used with pigskin. Type B gelatin is 
fonned when collagen (usually from bovine bone) is treated with alkali. The main 
difference between the two gelatin types is the pH at which they are neutral, also known 
as the isoelectric point (lEP). Type A gelatin is neutral between pH 8.0 and 9.0 and type 
B gelatin between pH 4.8 and 5.4. 
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Figure 4 Processes for breakdown of collagen into gelatin [35] 
There are many glycine, proline and 4-hydroxyproline residues in gelatin. A 
common structure is -Ala-Gly-Pro-Arg-Gly-Glu-4Hyp-Gly-Pro-. Mainly due to the 
nature of the side chains of gelatin, it has the ability to fonn reversible gels. 
Modifications of these side chains result in higher or lower solid to liquid transition 
temperatures [18]. The average melting temperature ofgelatin is about 37 C, although it 
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can vary slightly based on the gel strength, or Bloom value. Bloom values are used to 
categorize gelatin based on strength, where the higher Bloom values indicate higher gel 
strength and therefore higher melting/solidification temperatures [33]. To increase the 
melting temperature of gelatin above what high-bloom gelatin can offer, several 
modification methods are used to modify the chemical side chains, including chemical 
treatment and gamma irradiation. 
Albert Yang conducted preliminary research in 2005 towards the identification 
and selection of a material suitable to the needs of the project goals. His work focused on 
varying concentrations of food grade gelatin poured into thin films. While Albert 
narrowed the process for pouring and creating films of consistent thickness, the food 
grade gelatin was not able to withstand the incubation temperature of 37 degrees Celsius. 
Therefore, it is necessary to identify an effective modification technique to increase the 
solid-liquid transition temperature of gelatin. 
Section 2.02 Treatment Methods/or Gelatin 
(a) Glutaraldehyde 
Gelatin in its natural state is soluble in water if the temperature is above 20-25 C, 
where the "physical crosslink" is destroyed. After treatment with glutaraldehye, the 
gelatin becomes "chemically crosslinked" and insoluble in any solvent. The free 
aldehyde groups of glutaraldehyde form a Schiff base with the amino groups of lysine in 
gelatin. This crosslinking action between glutaraldehyde and gelatin occurs in various 
states: 1. both aldehyde groups of glutaraldehyde form the Schiff base with amino groups 
of lysine, 2. one of the two aldehyde groups reacts with an amino group of gelatin, but the 
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other remains unreacted, 3. some glutaraldehyde is included in complex graft polymers 
on the protein [23]. The unreacted aldehyde groups of glutaraldehye are toxic to cells. 
In order for the glutaraldehyde treated gelatin sheets to be used for cell cultures, it is 
necessary that the sheets be rinsed in glysine, which converts the aldehyde groups to 
carboxyl groups [23]. One protocol for treating gelatin films with glutaraldehyde 
suggests treating the films with 0.3% glutaraldehyde for 1 hour, washing with double 
distilled water for 3 hours under agitation, followed by Milli Q water for 1 hour under 
agitaion, rinsing with 100 mM glycine for 2 hours and finally washed in Milli Q water for 
1 hour under agitaion three times and dried in a sterile hood [1]. 
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Figure 5 Chemical reactions between gelatin and glutaraldehyde [23] 
(b) Transglutaminase 
Enzymatic treatment of gelatin with transglutaminase catalyzes the formation of 
isopeptide bonds between glutamine and lysine. Transglutaminase provides an 
alternative to treatment with glutaraldehyde, which has some drawbacks due to its 
toxicity [2]. Microbial transglutaminase has been approved for use in food and is 
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protected by and distributed exclusively by Ajinomoto [25]. It is important to note that 
Type A gelatin and not Type B gelatin should be used with transglutaminase treatment 
because base treatment hydrolyzes the amide groups and suppresses enzymatic 
crosslinking. 
(c) UV Irradiation 
Physical crosslinking may be induced by exposure to ultraviolet (IN) light. One 
source documented a dose of 500 IlW/cm2 for 40 minutes. Depending on the thickness of 
the sheets or films, this technique could allow for one side to be crosslinked, while the 
other side remains in its native state. The benefit to that would be increased cell viability 
on the side not treated [15]. 
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Section 2.03 Geometry ofScaffold 
(a) Conventional Scaffold Fabrication Techniques 
Solvent-casting particulate-leaching - This technique is performed using PLLA in 
chloroform and adding salt particles, which suspend uniformly. Once the solvent 
evaporates, the polymer is submerged in water and the salt dissolves leaving a porous 
matrix [28]. 
Gas foaming - PGLA is saturated with carbon-dioxide at high pressures and then 
rapidly brought back to atmospheric pressure, resulting in the formation of gas bubbles in 
the polymer [28]. 
Fiber meshes/fiber bonding - PLLA is dissolved in methylene chJoride and casted 
over PGA mesh. The solvent is dissolved and then the matrix is heated above the melting 
temperature ofPGA. The PLLA is then removed and a matrix ofPGA fibers, joined at 
the cross-point, remains [28]. 
Phase separation - Biodegradable synthetic polymer is dissolved in molten 
phenol, while biologically active molecules are added. The mixture is brought down in 
temperature to form a liquid-liquid phase, and even further to form a two-phase solid. 
The solvent is removed and a porous structure is left behind [28]. 
Melt molding - A Teflon mold is filled with PLGA powder and gelatin 
microshperes and the mold is heated above the glass transition temperature of PLGA. 
The PLGA particles bond together and the gelatin is then dissolved in water leaving a 
PLGA matrix. This technique allows matrices to be formed in specific geometries [28]. 
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Freeze drying - Synthetic polymers or natural polymers, such as collagen, can be 
frozen and freeze-dried to produce porous matrices. Freezing rate and pH can control 
pore size [28]. 
Solid Freeform Fabrication (SFF) - Involves building 3-D objects using layered 
manufacturing technology. Starting from the bottom and building layers up allows each 
layer to form a cross-sectional division [28]. 
(b) Cell Sheet Engineering 
Cell sheet engineering provides an alternative to the conventional 3-D 
biodegradable scaffolds described above. This relatively new concept is based on 
creating 3-D scaffolds by layering 2-D cell sheets. Cells are cultured to confluence and 
then instead of using enzymes that disrupt the cell-to-cell junction proteins, the cells are 
harvested as a continuous sheet by decreasing temperature. The resulting 3-D matrix is 
composed of viable cell sheets without any scaffolds [32]. 
The geometry of the scaffold is very important for cell viability. The cells are 
accustom to living in a certain geometry in vivo, so it is important that their environment 
is mimicked as closely as possible in vitro. The options for geometric configurations 
include flat films, tubes which provide one dimension of curvature, or hemispheres 
providing 2 dimensions of curvature. The hemispheres would most closely replicate the 
geometric configuration of an aveoli, the natural environment for mammary epithelial 
cell, however this geometry is very difficult to consistently produce. Collagen and 
gelatin films are the most common geometry for culturing fibroblasts and endothelial 
cells. Mammary epithelial cells grow to confluence on flat sheets, however, they are not 
able to secrete efficiently in this geometry. Tubes allow one dimension of curvature, 
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which is closer to replicating the cells' natural environment than flat sheets, and are 
reasonably efficient to manufacture. 
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Chapter 3. Objective 
Create a biocompatible film with suitable mechanical characteristics and 
processing properties for use in a bioreactor that also withstands extended periods of time 
in an aqueous solution at 37 degrees Celsius (the incubation temperature for epithelial 
cell lines) and can be optimized for cell survival (adjustable permeability). Develop a 
prototype of a self-contained system that facilitates the growth of epithelial mammary 
cells and promotes their secretion of lipid proteins. 
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Chapter 4. Outline 
The preliminary research for the project was more exploratory and qualitative 
than quantitative. Without a background in cell biology or much knowledge of gelatin or 
collagen, the two suggested materials for use, a lot of trial and error observational 
experiments were conducted. The various phases ofthe project are outlined below and 
are discussed in further detail throughout the next several pages. 
Material Development 
Phase I: Optimization of Gelatin Films 
Phase II: Optimization of Collagen Films 
Phase III: Modification of Gelatin Films 
Phase IV: Growing Viable Mammary Epithelial Cell Cultures 
Phase V: Developing Repeatable, Sterile Process for Cell Cultures on 
Treated Gelatin Films 
Geometry Development 
Phase I: Scaffold Geometry 
Phase II: Bioreactor Geometry 
Phase III: Modified System Proof of Concept 
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Chapter 5. Material Development 
As stated in the purpose of this research, the first goal was to develop a substrate 
that would facilitate the growth of epithelial mammary cells. Previous efforts to 
accomplish this revealed that the main constraints in selecting appropriate materials are 
melting temperature, biocompatibility, and ease of use. The melting temperature of the 
material must be above 37 degrees Celsius so that the material doesn't lose its integrity 
when it is subjected to incubation temperature. The biocompatibility of the material is 
important so that the cells are able to grow abundantly on the chosen substrate. Some 
materials promote cell growth better than others and materials should be analyzed 
comparatively so that the best substrate for cell growth is chosen. Ultimately, whatever 
material is chosen, it is important that it is easy to work with and will give repeatable 
results. A material that encourages cell growth but cannot be easily manipulated into 
working sheets, tubes or other configurations is not beneficial to the ultimate goal of this 
project. 
Section 5.01 Phase I: Optimization ofGeiatin Films 
(a) Materials and Methods 
Since the previous research was completed using gelatin, the experiment began by 
exploring the properties of gelatin. Most food grade gelatin has a melting temperature of 
35-37 degrees Celsius so that it will "melt in your mouth". For this reason, it was 
obvious that food grade gelatin alone would not be an adequate material for the purposes 
of this project. However, based on previous observations and experiences, gelatin is 
known to be a very versatile substance and one with which it is very easy to work. 
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Because of this, it was decided to continue to use gelatin as a base material and look into 
treatment options for increasing the melting temperature of the gelatin. 
Gelatin was to be the base for scaffold, therefore it was important that the 
properties of the gelatin sheets created were optimized. A Design of Experiments (DOE), 
shown in Table 1, was generated and performed to find the thickness, drying rate and 
concentration of gelatin that combined to create the optimal gelatin sheet for this 
application. For our purposes, the thickness of the gelatin sheets was measured and 
controlled by varying layers ofmasking tape that constrained the gelatin during the 
drying process. The drying rates were based on high, 38 degrees Celsius, and low, 4 
degrees Celsius, temperature settings. Powdered gelatin gelatin was dissolved into water 
at 7 g per 50 mL and 2 g per 50 mL. 
Concentration Drying Thickness 
DOE 
(g/SO mL) Temperature (OC) (Layers of tape) 
HIGH 7 38 3 
LOW 2 4 1 
Table 1 Design of experiments with varying concentrations of gelatin, drying 
temperature and thickness for optimization of gelatin films. 
The experiment was conducted using stainless steel plates with masking tape 
forming square constraints for the gelatin to be poured into. Because of the fluid 
properties of liquid gelatin, it will pool together unless it can adhere to something. The 
edges of the masking tape absorb minimal amounts of the liquid gelatin mixture and 
allow it to dry conforming to the shape that the masking tape outlines. This helps control 
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the thickness of the resulting sheets as well since the gelatin is forced to occupy a 
specified area instead of pooling together in the center. Initially, a thennal controller was 
used to control the temperature cycles. The thennal controller was set to subject the 
samples to the extreme temperatures for either one hour at 38 degrees Celsius or two 
hours at 4 degrees Celsius and then the samples were to sit for a least two hours before 
being removed from the plates. Unfortunately, the thennal cycler broke in the midst of 
these experiments, so instead the experiments were repeated using a hot plate for the high 
temperature setting and a refrigerator for the low temperature setting. This set up did not 
allow for as accurate temperature control, but for observational purposes it gave adequate 
data. 
The sheets from the DOE were tested in 37 degree Celsius water to detennine if 
they would remain sheets at incubation temperature and visual observations were also 
made. 
(b) Discussion 
The following observations were made regarding the gelatin films that resulted 
from altering the three variable of the DOE. Higher drying temperatures and higher 
concentrations of gelatin led to very brittle gelatin films. Thin sheets were also very 
brittle and flaky to the point that they were often difficult to remove from the plates. In 
addition to the single layer of tape, low concentration of gelatin also made very thin, 
brittle sheets of gelatin. The low temperature resulted in thick sheets of gel which didn't 
dry until they were left at room temperature for a least an hour, and even then they 
resulted in non-unifonn sheets. 
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In addition to visual observations, the sheets from the DOE were also tested in 37 
degree Celsius water. The thicker sheets made with three layers of tape and higher 
concentrations of gelatin lasted longer in the water, but eventually all of the sheets 
dissolved. It was apparent that something had to be added to the gelatin sheet to increase 
their melting temperature. However, the DOE resulted in a consistent process for 
producing manageable gelatin sheets. 
Section 5.02 Phase II: Optimization ojCollagen Films 
(a) Materials and Methods (First Iteration) 
Type I bovine collagen isolated from achilles tendon was ordered from Sigma 
Aldrich. The collagen arrived in powdered form. The challenge for the applications of 
this project was to transform the collagen from its natural state to a form that would meet 
our objectives of pliable sheets with high melting temperatures. Having never worked 
with collagen before, this turned out to be a much bigger task than anticipated. An 
attempt was made to dissolve the collagen using 4 mg collagen per mL 0.017 M acetic 
acid. 
(b) Discussion (First Iteration) 
The collagen failed to dissolve into the acetic acid solution. Several other 
concentrations of acetic acid, up to .2 M, also failed to dissolve the collagen, even over 
the course of several weeks and at varying temperatures. Titration with 0.1 M NaOH to 
reach a pH of 5.5, which was described in one referenced paper, also failed [8]. After 
several weeks and multiple attempts without success, reference back to the Sigma 
description of the product ordered showed that the collagen type we were working with 
was classified as "insoluble". 
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(c) Materials and Methods (Second Iteration) 
Soluble type I bovine collagen isolated from calf skin was ordered from Sigma to 
replace the insoluble collagen. The soluble collagen was dissolved successfully into 
0.017 M acetic acid. The collagen solution was poured directly onto the metal plate and 
onto a dried gelatin film. 
(d) Discussion (Second Iteration) 
The layer of collagen applied to the plate did not form enough of a film to remove 
from the plate. The layer of collagen solution applied to the surface of a gelatin sheet and 
dried was tested in 37 degree Celsius water. The gelatin dissolved leaving behind a very 
thin collagen film floating in the water. The film was so thin that it collapsed on itself 
when it was removed from the water and did not regain its integrity. Although this wasn't 
fully successful, it was promising and led to further experiments down a similar path. 
Section 5.03 Phase III: Modification ofGelatin 
(a) Materials and Methods (First Iteration) 
Further experiments with gelatin were conducted in parallel with the collagen 
experiments. In order to increase the mechanical properties and melting temperatures of 
gelatin, chemical crosslinking was applied. Two treatments were considered; 
transglutaminase and glutaraldehyde. Transglutaminase creates an irreversible covalent 
bond between glutamine and lysine, whereas glutaraldehyde forms an irreversible lysine-
lysine bond [25]. These irreversible bonds allow the gelatin to survive higher 
temperatures. Transglutaminase is a proprietary formulation and is therefore difficult to 
obtain. Glutaraldyhde is easily obtainable through Sigma-Aldrich, and so was chosen as 
the chemical of choice for the following experiments. The 25% glutaraldehyde in water 
solution from Sigma was diluted with Milli-Q water to obtain a 2.5% solution for the first 
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experiment. Below are the procedures that were followed for the first experiment with 
glutaraldehyde. 
Process: 
1. Mix gelatin and glutaraldehyde and cast films 
a. Mix 20% gelatin solution (made with 300 bloom gelatin and water) 
b. Add glutaraldehyde in three different ratios of gelatin to glutaraldehyde: 64: 1, 
128:1,265:1 
c. Cast three sheets (30mm x 30mm) of each solution with two layers of tape on a 
metal plate 
d. Let dry at room temperature 
2. Treat gelatin sheets with glutaraldehyde solution 
a. Cast 20% gelatin solution sheets (30mm x 30mm) with two layers of tape on 
metal plates 
b. Submerge gelatin sheets into 2.5% glutaraldehyde solution for 20 minutes 
c. Rinse with de-ionized water 
d. Submerge sheets into 1% glycine solution for 30 minutes 
e. Rinse with de-ionized water 
3. Treat only part of gelatin sheet 
a. Cast 20% gelatin solution sheets (30mm x 30mm) with two layers of tape on 
metal plates 
b. Use pipet to treat part of gelatin sheet with 2.5% glutaraldehyde solution 
c. Rinse with de-ionized water 
d. Submerge sheets into 1% glycine solution for 30 minutes 
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e. Rinse with de-ionized water 
(b) Discussion (First Iteration) 
When the gelatin and glutaraldehyde were mixed together it almost immediately 
transfonned from a liquid to a semi-solid. The liquid turned from clear to an orange 
dense gel. The glutaraldehyde caused cross-linking in the gelatin that made it impossible 
to pipet the liquid. Further experiments were perfonned with differing concentrations of 
gelatin and glutaraldehyde, none of which resulted in a solution that was pipetable. It 
was concluded that the reaction between the lysine bonds happens too quickly for this 
method to work. As a result, Method 1 of the above processes was eliminated. 
The gelatin sheets prepared and then treated with glutaraldehyde perfonned very 
well. The glutaraldehyde again caused cross-linking of the gelatin which was noted 
visually with the change of color to orange. The same was observed for the gelatin sheet 
treated with Method 3, which consisted of a square ofglutaraldehyde in the center of the 
gelatin sheet. The sheets processed with Method 2 and 3 above, were tested in 37°C 
water and did not dissolve. The treated sheets were tested along side untreated sheets 
which dissolved within 2-3 minutes. In the case of the Method 3 sheet, which was 
partially treated, the untreated portions dissolved leaving behind the square which had 
been treated with glutaraldehyde. The treated sheets were left in the water and kept their 
integrity for over an hour at temperatures up to 60 degrees. These results were very 
promising towards the goal of the project. However, while the design constraint of a high 
melting temperature seemed to have been met, the 2.5% glutaraldehyde solution created 
sheets of gelatin which were very rigid. 
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(c) Materials and Method (Second Iteration) 
Experiments were performed with lower dilutions of glutaraldehyde and different 
gelatin concentrations, utilizing the DOE shown in Table 2, until an optimal combination 
was obtained. 
Glutaraldehyde Concentrations 
3.0% 5.0% 7.0% 10.0 % 
0.1 % X X X X 
0.3 % X X X X 
Table 2 Design of experiments for varying glutaraldehyde and gelatin 
concentrations 
(d) Discussion (Second Iteration) 
The DOE with lower glutaraldehyde concentrations proved that 10% gelatin 
treated with 0.1 % glutaraldehyde showed to be the best combination at this point. This 
combination created a gelatin film that was strong and durable, yet very flexible and 
pliable. 
Section 5.04 Phase IV: Developing Viable Mam1lUlry Epithelial Cell Cultures 
(a) Material and Methods 
Once a reliable and repeatable process was developed for creating sheets of gelatin with 
the desired properties, the cells could finally be introduced to the experiments. Bovine 
mammary cells were thawed from cryovials to create our control plates. M 199 growth 
medium with bovine serum, penicillin and insulin was used to incubate the cells. The 
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cells grew abundantly in the control plates which were empty petri dishes with cells and 
growth medium only. The cells became confluent on the bottom of the dishes overnight. 
Once confluent, the cells were split into petri dishes containing various combinations of 
gelatin sheets treated with glutaraldehyde following the combinations listed in Table 2. 
The cells were left to incubate overnight. 
(b) Discussion 
After 24 hours the cells were observed under a microscope and unfortunately the Petri 
dishes with gelatin film contained mostly dead cells floating in the medium. The control 
plate contained confluent, healthy cells. It was thought that perhaps the glutaraldehyde 
was toxic to the cells so lower concentrations of glutaraldehyde were tested. Petri dishes 
were prepared following the process described above with lower concentrations of 
glutaraldehyde. The cells were left to incubate overnight and after 24 hours most of the 
cells in the experimental plates were dead again. 
Section 5.05 Phase V: Creating Repeatable, Sterile Procedure/or Culturing Cells on 
Treated Gelatin Films 
(a) Materials and Methods (First Iteration) 
More literature was consulted and it was discovered that rinse times for water and glycine 
needed to be increased dramatically. The rinse time for the first MQ water rinse was 
increased to 3 hours, the 30 minute glycine rinse went up to 2 hours, and the final MQ 
water rinse went to 3 hours with fresh water every hour. Along with the increased times, 
the rinses are also to be done under agitation to increase that amount of glutaraldehyde 
that is rinsed off. The DOE shown in Table 2 was repeated using these new rinse times. 
The process is shown below in Figure 6 Process for glutaraldehyde treatment of gelatin 
films in sterile hood. 
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Figure 6 Process for glutaraldehyde treatment of gelatin films in sterile hood 
(b) Discussion (First Iteration) 
After 24 hours the cells looked better in the experimental plates than they had before, but 
still weren't confluent. An additional observation was that the cells were more confluent 
on the bottom of the Petri dish than they were on the gelatin. There was a small barrier of 
dead cells and bare Petri dish around the square sample of gelatin. There was definitely 
something about the gelatin sheets that was not conducive to cell growth. 
Part of the problem of having a very limited background in cell biology, is that there is a 
large learning curve that translated into a lot of trial and error for this project. The 
problem with the current process turned out to be very simple. While the glycine serves 
to neutralize the free glutaraldehydes and sterilize any microbial contamination, it does 
not eliminate material contamination. The sheets that we were using were prepared with 
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gelatin and tap water which contains many trace metals that contaminate the sheets and 
compromise cell growth. 
(c) Materials and Methods (Second Iteration) 
Several more steps were added to the preparation of the films to ensure sterility. The 
gelatin and MQ water mixture was autoclaved before the sheets were poured onto plates 
that were also autoclaved. Dense polycarbonate plates were used instead ofmetal plates 
and the tape used was kept in the sterile hood to avoid introducing additional 
contamination. The sheets were prepared in the hood and gloves and sterile forceps were 
used at all times. In addition, the process shown above in Figure 2 was modified to 
minimize handling of the films. Instead of transferring the sheet from Petri dishes for 
each treatment, the liquid was aspirated from the Petri dish after each treatment using a 
vacuum pump. Cells were plated once again according to the DOE in Table 2. 
(d) Discussion (Second Iteration) 
This time, after 24 hours there were healthy cells growing on the gelatin sheets. A 
sununary table is shown below with several combinations of the DOEs that were 
performed during the experimental phases of this project. The low concentrations of 
gelatin with low glutaraldehyde concentrations create films that are structurally too week 
to survive the incubation temperature for manunary epithelial cells of37 dc. Films with 
concentrations of glutaraldehyde greater than 3.0%, were structurally too rigid for three 
dimensional matrices desired. It was also observed that at concentrations of 
glutaraldehyde greater than 3.0%, cell growth was prohibited. Films with less than 3% 
gelatin, were very flimsy and difficult to manipulate. These films were too fragile for the 
application of this project. Films that were made with more than 10% gelatin were too 
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thick for use in a bioreactor. These high concentrations of gelatin yield sheets with low 
penneability and often developed brittle mechanical properties after treatment with 
glutaraldehyde. The unshaded regions represent the optimal ranges for both structural 
use and for cell proliferation. 
Gelatin Concentrations 
<3.0% 3.0% 5.0% 7.0% 10.0% > 10.0 % 
<0.1 % 
0.1 % I 
0.3 % 
>0.3 % 
II 
Table 3 Un-shaded region shows optimal gelatin and glutaraldehyde concentrations 
for mammary epithelial cell growth and structural use. 
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Figure 7 Mammary epithelial cells on glutaraldehyde treated gelatin under lOx 
magnification 
Figure 7 shows the cells under lOx magnification. This was a huge breakthrough 
for the project and gave proof of concept to move onto the next level, which was creating 
a three-dimensional area for cell growth. 
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Chapter 6. Geometry Development 
Section 6.01 Phase I: Scaffold Geometry 
(a) Preliminary Exploratory Research 
The first configuration that was attempted was a very simple three-dimensional 
shape, a tube. This was most logical since the current process produced square sheets 
that in theory could easily be rolled into tubes. As simple as this concept sounds, there 
were still many obstacles that had to be overcome before a repeatable process was 
developed. The [lIst process that was attempted involved rolling the untreated gelatin 
tubes around a sterile rod. When hydrated with water, the gelatin becomes sticky and 
will easily stick to itself, so the method involved re-hydrating the edges and sticking them 
together. While this worked, re-hydrating only part of the sheet created uneven and 
unsymmetrical tubes. Another method that was attempted without success was casting 
fIlms on the rods and letting them dry. These proved impossible to remove from the rod, 
leaving them unusable. Yet another method was to treat the sheets with glutaraldehyde 
prior to forming tubes. This method was also unsuccessful, as the glutaraldehyde makes 
the sheets very slippery and hydrophobic, eliminating the possibility of adhering the sheet 
to itself. A combination of two of the previous methods proved to be successful. 
(b) Materials and Methods 
The gelatin sheets were prepared and dried completely as sheets. Then the sheets 
were fully re-hydrated in water and carefully wrapped around the rod. Glass and Teflon 
rods were both used and for this last method, the Teflon rods gave the most consistent 
results. First, an attempt was made to remove the tubes from the rod and treat the gelatin 
tubes with glutaraldehyde. However, the tubes didn't maintain their structure very well 
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during treatment without the rod for support. So a second attempt was to treat the gelatin 
tubes prior to removing them from the rods. 
(c) Discussion 
The rods provided support during treatment and also made it very simple for 
handling purposes. Being able to transport the tube using the rod eliminated possible 
contamination. Removing the tubes from the rod before they were completely dry 
seemed logical to prevent them from adhering to the rod; however they were too fragile 
at that stage and began to tear. The tubes were left to dry overnight and were easily 
removed from the rods once they were dry. A second proof of concept was achieved. By 
developing a method that could consistently produce gelatin tubes, the next step of 
integrating the materials into the system could begin. 
Section 6.02 Phase II: Bioreactor Geometry 
(a) Material and Methods 
The goal for developing a system was to create a three-dimensional environment 
that would induce mammary cells to grow and secrete as they do in their natural 
environment. Previous research had shown that mammary cells plated on the bottom of 
Petri dishes will produce secretions, but cannot secrete their products as they do 
naturally. The goal of this project was to create a three-dimensional system that could be 
polarized giving the cells direction in which to secrete their products. In order to 
integrate the materials and process for creating and treating the gelatin tubes, the design 
for the system had to be modular. Another design constraint was that all components of 
the system had to be autoclavable to ensure sterility. The ultimate goal for the project 
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was to collect the secretions from the cells and therefore the system had to have an outlet. 
Based on these design constraints the design concepts below were the first brainstormed. 
c:. 
'Tft, 
l L" U·., rJ1 
=r ') 
1ft 
Figure 8 Bioreactor Design - Option 1
Olr 
Figure 9 Bioreactor Design - Option 2
Figure 10 Bioreactor Design - Option 3
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Development continued with the prototype shown in Figure 6. Autoclavable parts 
were purchased from Sigma Aldrich. The system went together easily; the challenging 
part was integrating the gelatin tubes and cells into the system. Since the process for 
creating the tubes involved using the Teflon rod for support, that concept was 
incorporated into the system design. The gelatin sheets were secured to two quick release 
valves that easily snap in and out of the system. Holes were drilled into the valves that 
allowed the Teflon rods to pass through and provide support for the gelatin during the 
glutaraldehyde treatment. After the treatment, the rod was removed, leaving the gelatin 
tube secured to the valves on either end (Figure 11). 
Figure 11 Modular section of bioreactor with unseeded gelatin tube. 
(b) Discussion 
The modular design that was chosen made the system easy to create and made 
integrating the previously developed material relatively easy. With the geometry created 
and the materials chosen, the only thing left to do was to prove that everything would 
work together as a system. 
32
Section 6.03 Phase III: Modified systemfor proofofconcept 
(a) Materials and Methods 
To simplify the experiment, an attempt to grow cells inside the tubes was isolated 
to the modular section shown in Figure 12. 
Figure 12 Modular section of bioreactor with seeded gelatin tube 
The falcon tube was filled so that the gelatin tube was surrounded with growth 
medium. Cells suspended in growth medium were injected into the top valve using a 
pipette. The weight of the top valve caused the gelatin tube to collapse slightly, but there 
was still enough shape to carry out the experiment. 
(b) Discussion 
After two days, the section was dissected and examined under a microscope 
(Figures 8-10). There were cells alive and adhering to the gelatin tube. This proved the 
concept that mammary cells would grow in a three-dimensional environment. 
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Figures 8-10 lOx Images of dissected gelatin tube showing healthy, adhered 
mammary cells 
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Chapter 7. Proposed Continuation Efforts 
The infonnation presented above demonstrates a proof of concept for culturing 
epithelial mammary cells in a three-dimensional environment. The extensive 
experiments performed to optimize the materials used, as well as processing steps, proved 
to be effective when combined with the modular bioreactor system. The cell viability 
shown within the bioreactor provides enough confidence in the materials and system to 
be able to continue research in this area. As mentioned previously, the ultimate goal of 
this ongoing bioreactor project is for the cells to secrete as they do in vivo. As a follow 
up to this project, it is recommended that the secretory functions of the epithelial 
mammary cells within the bioreactor system are tested. Now that it has been proven that 
the mammary cells are capable of growing to confluence within the tubular section of the 
bioreactor, the next step would be to polarize the system to induce cell secretion. 
Recommendations for polarization include replacing the media on the basal side (outside 
of tube) with lactation media to induce cell differentiation and milk synthesis. The media 
on the lumen side (inside the tube) can then be replaced with phosphate buffered saline 
(PBS). The PBS should aide in the polarization process, and will also make it easy to 
purify the cell secretion products due to their suspension in PBS. A quantitative 
comparative analysis of the lactogenic response of mammary cells grown on flat gelatin 
substrates versus those grown in a tubular polarized environment would be the next 
recommended step for this project. 
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Chapter 8. Conclusion 
This preliminary research has provided a very solid basis for further development 
of a three dimensional polarized environment conducive to mammary cell viability and 
increased secretion. This system will complement the extensive genomic and proteomic 
research in mammary gland biology. This area of research is currently limited by the 
expense and low success rate associated with using transgenic animals as bioreactors. 
This system will provide an alternate solution and will provide complementary data to the 
genomic or proteomic analysis of the mammary gland. The possible applications for this 
system, once fully developed, are nearly endless. The fields of health and secretion 
biology for commercial applications could benefit from a new model for 
biopharmaceutical production, which may contribute to the improvement of current 
bioreactor systems. Once fully developed and scaled up, the system could be applied to 
tissue engineering projects. Since mammary cells are a specific type of epithelial cells, 
this research should be compatible with other epithelial cell types and therefore 
applicable to tissue, such as skin. Preliminary research suggests that this system could 
possibly be a solution to the limitation of growing multiple cell types functioning within 
a larger-scale system. Components of this research could also be applied as a seed to the 
development of manufacturing and packaging techniques for "living mechanisms" such 
as biosensors, bio filters, and bioremediation efforts. The primary goal of this research 
however, was to develop a system that would be used to mimic a living system. The 
resulting system would serve as an in vitro factory for the production of 
biopharmaceuticals. Thus, the understanding and controlling of mammary epithelial 
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cells, partially accomplished through this research, is of high value to the pharmaceutical 
industry as a potential means for the production of complex drugs. 
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